Maharashtra FDA Cancels Cipla Pune Distribution Unit’s Drug Licence Over Reactin Plus Violations
MUMBAI, India — The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licences of a Carrying and Forwarding
MUMBAI, India — The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licences of a Carrying and Forwarding
The authority becomes the tenth in Africa and the first in a Portuguese-speaking African country to reach ML3, covering medicines and imported vaccines.
EFDA assessed its system for devices and in vitro diagnostics against more than 250 WHO indicators, setting a roadmap towards formal benchmarking after reaching Maturity Level 3 for medicines last year.
The regulator has also issued the country’s first Good Pharmacy Practice standards and says it is supporting 13 new manufacturers, as it sets out its record at the Kenya Health Summit.
The agency put the value of the consignment at 301.1 billion naira and carried out the destruction under a Federal High Court order, with opioids among the substances.
ECOWAS wants Nigeria’s reporting to WENDU improved and the monitoring network expanded to at least 20 centres, though no funding, budget or timeline was stated.
The regulator named no products or suppliers but says unapproved weight-loss injectables, performance enhancers and codeine painkillers are increasingly sold through social media, gyms and beauty outlets.